Brief: Glenmark Pharmaceuticals Enters Into Licensing Agreement With Yuhan Corp

Yuhan

10/01/2019 03:38

Jan 10 (Reuters) - Glenmark Pharmaceuticals Ltd  GLEN.NS :
    * SAYS ENTERS INTO AN EXCLUSIVE LICENSING AGREEMENT WITH
YUHAN
CORPORATION
    * DEAL WITH YUHAN CORP TO COMMERCIALIZE INVESTIGATIONAL
SEASONAL
ALLERGIC RHINITIS NASAL SPRAY RYALTRIS IN SOUTH KOREA
    * CO TO BE RESPONSIBLE FOR MANUFACTURING AND SUPPLY OF
PRODUCT,
WHILE YUHAN WILL BE RESPONSIBLE FOR REGULATORY FILING
    * CO WILL RECEIVE AN UPFRONT PAYMENT, REGULATORY AND
COMMERCIAL
MILESTONE PAYMENTS AS WELL AS ROYALTIES FROM YUHAN

Source text - http://bit.ly/2D1ezy8
Further company coverage:  GLEN.NS 

 ((Reuters.Briefs@thomsonreuters.com;))